Dr. Thomas David Lobue, MD

Dr. Lobue practices at Lobue Laser and Eye Care Medical Center Inc in Murrieta, California.

Dr. Lobue's NPI, 1306887435, was assigned on June 9, 2006. Dr. Lobue graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1983. Dr. Lobue holds California license G598470.

Dr. Lobue's primary practice is Lobue Laser and Eye Care Medical Center Inc, at 40700 California Oaks Rd, Murrieta, CA 92562 in Riverside County. The practice phone is (951) 696-1135.

Dr. Lobue's primary practice is Lobue Laser and Eye Care Medical Center Inc in Murrieta, California. Dmand AI also links Dr. Lobue to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lobue practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Lobue's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Lobue is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Lobue is licensed in California.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, eye infection or inflammation, eyelid inflammation, glaucoma and glaucoma surgery among the conditions Dr. Lobue treats.

CMS data shows 1,426 Medicare services from Dr. Lobue across 13 procedure codes in 2024, for 473 Medicare patients. Medicare paid $97,763 for them.

CMS counts 473 Medicare patients who saw Dr. Lobue in 2024. The largest group is 75 to 84, with 200 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.22, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lobue's median patient age at 74, with 57% women.

In 2024, Dr. Lobue wrote 3,231 Medicare Part D claims for 689 patients. 60% of them were for generic drugs. CMS names the drug for 3,129 of them, across 26 drugs with 11 or more claims each, at $252,793 in total drug cost. In 2023, CMS named 4,271 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Lobue for performance year 2024, reported as part of a group. Dr. Lobue accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 52 procedures of cataract surgery by Dr. Lobue, more than 64% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Dr. Lobue, published from 2018 to 2020. 2018 was the busiest year, with 2. Dr. Lobue has published most often in Am J Ophthalmol. Dr. Lobue's most frequent co-authors are Stephen Lobue, MD, Prashant Dilip Tailor, MD and Richard A. Giovane, MD.

Dmand AI links Dr. Lobue to 2 clinical trials. Conditions studied include Cataract and Lens Diseases.

CMS Open Payments shows 202 general payments to Dr. Lobue from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 84% of the total. Alcon Laboratories Inc paid the most, $5,186. It also lists 6 research payments totaling $120,530 from 2016 to 2018.

Dmand AI lists 2 awards for Dr. Lobue, most recently CMS Stage 1 EHR in 2013.

Dr. Lobue graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1983. Dr. Lobue is a member of AAO.

Dr. Lobue is in network with 19 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.